Jansen L - Search Results

1

Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy.

de Niet A, Stelma F, Jansen L, Sinnige MJ, Remmerswaal EB, Takkenberg RB, Kootstra NA, Reesink HW, van Lier RA, van Leeuwen EM. de Niet A, et al. Among authors: jansen l. J Hepatol. 2016 Mar;64(3):539-46. doi: 10.1016/j.jhep.2015.10.013. Epub 2015 Oct 24. J Hepatol. 2016. PMID: 26505119

2

Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues.

Jansen L, Kootstra NA, van Dort KA, Takkenberg RB, Reesink HW, Zaaijer HL. Jansen L, et al. J Infect Dis. 2016 Jan 15;213(2):224-32. doi: 10.1093/infdis/jiv397. Epub 2015 Jul 27. J Infect Dis. 2016. PMID: 26216905 Clinical Trial.

3

HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy.

Stelma F, Jansen L, Sinnige MJ, van Dort KA, Takkenberg RB, Janssen HL, Reesink HW, Kootstra NA. Stelma F, et al. Among authors: jansen l. J Viral Hepat. 2016 Aug;23(8):652-9. doi: 10.1111/jvh.12525. Epub 2016 Mar 4. J Viral Hepat. 2016. PMID: 26945896

4

Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir.

Willemse SB, Jansen L, de Niet A, Sinnige MJ, Takkenberg RB, Verheij J, Kootstra NA, Reesink HW. Willemse SB, et al. Among authors: jansen l. Antiviral Res. 2016 Jul;131:148-55. doi: 10.1016/j.antiviral.2016.05.002. Epub 2016 May 4. Antiviral Res. 2016. PMID: 27155352

5

HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up.

Stelma F, van der Ree MH, Jansen L, Peters MW, Janssen HLA, Zaaijer HL, Takkenberg RB, Reesink HW. Stelma F, et al. Among authors: jansen l. J Viral Hepat. 2017 Dec;24(12):1107-1113. doi: 10.1111/jvh.12738. Epub 2017 Jul 29. J Viral Hepat. 2017. PMID: 28632898

6

Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir.

de Niet A, Jansen L, Zaaijer HL, Klause U, Takkenberg B, Janssen HL, Chu T, Petric R, Reesink HW. de Niet A, et al. Among authors: jansen l. Antivir Ther. 2014;19(3):259-67. doi: 10.3851/IMP2707. Epub 2013 Nov 21. Antivir Ther. 2014. PMID: 24256626 Clinical Trial.

7

HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels.

Jansen L, de Niet A, Stelma F, van Iperen EP, van Dort KA, Plat-Sinnige MJ, Takkenberg RB, Chin DJ, Zwinderman AH, Lopatin U, Kootstra NA, Reesink HW. Jansen L, et al. J Hepatol. 2014 Oct;61(4):730-7. doi: 10.1016/j.jhep.2014.05.004. Epub 2014 May 10. J Hepatol. 2014. PMID: 24824278

8

An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis B.

Jansen L, de Niet A, Makowska Z, Dill MT, van Dort KA, Terpstra V, Bart Takkenberg R, Janssen HL, Heim MH, Kootstra NA, Reesink HW. Jansen L, et al. Liver Int. 2015 Jul;35(7):1824-32. doi: 10.1111/liv.12768. Epub 2015 Jan 21. Liver Int. 2015. PMID: 25533046 Clinical Trial.

9

Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.

Stelma F, de Niet A, Tempelmans Plat-Sinnige MJ, Jansen L, Takkenberg RB, Reesink HW, Kootstra NA, van Leeuwen EM. Stelma F, et al. Among authors: jansen l. J Infect Dis. 2015 Oct 1;212(7):1042-51. doi: 10.1093/infdis/jiv180. Epub 2015 Mar 19. J Infect Dis. 2015. PMID: 25791117

10

Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients.

van der Ree MH, Jansen L, Kruize Z, van Nuenen AC, van Dort KA, Takkenberg RB, Reesink HW, Kootstra NA. van der Ree MH, et al. Among authors: jansen l. J Infect Dis. 2017 May 1;215(9):1421-1429. doi: 10.1093/infdis/jix140. J Infect Dis. 2017. PMID: 28368488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

918 results

Search Page